James Joseph Martin is Co-CEO and CFO of Cocrystal Pharma, Inc.. Currently has a direct ownership of 40,569 shares of COCP, which is worth approximately $74,241. The most recent transaction as insider was on Oct 09, 2024, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.6K
n/a 3M change
n/a 12M change
Total Value Held $74,241

James Joseph Martin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 49.65%
40,569 Common Stock

Also insider at

PETV
PetVivo Holdings, Inc. Healthcare
JJM

James Joseph Martin

Co-CEO and CFO
Miami, FL

Track Institutional and Insider Activities on COCP

Follow Cocrystal Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COCP shares.

Notify only if

Insider Trading

Get notified when an Cocrystal Pharma, Inc. insider buys or sells COCP shares.

Notify only if

News

Receive news related to Cocrystal Pharma, Inc.

Track Activities on COCP